Showing results (11-20 of 122) with videos related to
Sort By:
Pageof 13
Anti-Cancer Drugs|September 1, 1996
The abamectin derivative ivermectin is a potent P-glycoprotein inhibitorA Didier, F LoorJournal of Immunological Methods|November 23, 1987
An enzyme-linked lectin-binding assay on cells (CELLBA) for the comparison of lectin receptor expression on cell surfacesC Gavériaux, F LoorInternational Archives of Allergy and Applied Immunology|January 1, 1987
Effect of glycoprotein-processing inhibitors on the mouse IgE binding capacity of rat basophilic leukemia cellsC Gavériaux, F LoorInternational Journal of Cancer|October 1, 1994
Myeloid and lymphoid cell alterations in normal mice exposed to chemotherapy with doxorubicin and/or the multidrug-resistance reversing agent SDZ PSC 833S Froidevaux, F LoorAnnales D'Immunologie|March 1, 1983
Activity of some natural and modified (fluorescent) cyclosporins on T cellsM Koponen, F LoorInternational Archives of Allergy and Applied Immunology|January 1, 1989
Proliferation of interleukin 2 dependent cytotoxic T cell line cells. Different protein kinase C activators achieve the same maximal promotion, but with distinct dose-response profilesC Gavériaux, F LoorAnti-Cancer Drugs|December 1, 1993
Atypical multi-drug resistance (MDR): low sensitivity of a P-glycoprotein-expressing human T lymphoblastoid MDR cell line to classical P-glycoprotein-directed resistance-modulating agentsB Jachez, F LoorThe Journal of Experimental Medicine|November 1, 1973
Differentiation of T-cell precursors in nude mice demonstrated by immunofluorescence of T-cell membrane markersF Loor, B KindredAnnales D'Immunologie|September 1, 1983
Cyclosporin-binding sites of murine sensitive and resistant lymphoid cell linesM Koponen, F LoorThe Journal of Experimental Medicine|May 1, 1974
Activity of host-derived T cells which differentiate in nude mice grafted with co-isogenic or allogeneic thymusesB Kindred, F LoorPageof 13